How many people have a Neuralink implant, where the trials run and what results are published. Every figure sourced and dated; reviewed quarterly.

A collision may have left these galaxies without dark matter. That spells trouble for alternative gravity theories.

Gavin Newsom calls comments ‘deranged and dangerous’ after president tells Nebraska rally: ‘They can take out a city’

The Chinese Academy of Sciences (CAS), China's top state research body, announced on 28 September 2026 that it had released its 15th Five-Year development plan covering 2026 to 2030. The plan lists brain-computer interfaces among its 'important priority fields' (重要优先领域), alongside integrated circuits, artificial intelligence, quantum science and technology, life sciences and biotechnology, and controlled nuclear fusion. CAS will organise research around a '3+4+X' regional layout with Shanghai as one of three strategic highlands, and will explore forming field-based research consortia, mission-based task forces and platform-based facility clusters across its institutes. CAS already runs its own invasive BCI programme: a system developed at its Shanghai Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) was implanted in its first trial participant at Huashan Hospital in March 2025, and StairMed, founded by CEBSIT researcher Zhao Zhengtuo, entered the National Medical Products Administration's innovative device green channel in November 2025 with a market target of around 2028. CAS was one of the seven co-signatories of the 2025 BCI industry implementation opinions. The plan lands six days after Premier Li Qiang inspected BCI products in Shanghai and called future industries a blue ocean for advanced manufacturing. No BCI budget, programme names or milestones have been made public.

Physicists at Johannes Gutenberg University Mainz (JGU) have developed a technology that uses quantum sensors to measure biomagnetic signals, such as heart activity. Researchers from the DIAQNOS (DIAmond-based Quantum Sensing for NeurOSurgery) flagship project, coordinated by Dr. Arne Wickenbrock in Mainz, have demonstrated the potential of quantum technology for future medical applications.